Karen M. Cruz Arenas
FDA investigator
Appears on 1 document from 2024, mostly at sites in Missouri. Most often cites design controls (21 CFR 820.30(d)).
- 1
- Documents on file
- 9.0
- Observations per 483
- 2024
- First seen
- 2024
- Most recent
What they cite most
From 9 observations- 21 CFR 820.30(d)Design controls2
- 21 CFR 211.110(a)Sampling and testing of in-process materials and drug products1
- 21 CFR 211.113(b)Control of microbiological contamination1
- 21 CFR 211.160(b)General requirements1
- 21 CFR 211.165(d)Testing and release for distribution1
- 21 CFR 211.192Production record review1
Activity by year
2024: 1
Where
Missouri 1
Often inspects with
Is Karen M. Cruz Arenas coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
1 document, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2024-06-05 | 483 Meridian Medical Technologies, LLCJun 5, 2024 · St. Louis, Missouri | St. Louis, Missouri | 9 |
About this profile
What does Karen M. Cruz Arenas inspect?
Karen M. Cruz Arenas appears on 1 document on file covering 1 site, mostly in Missouri.
What do they cite most often?
21 CFR 820.30(d) (design controls), followed by 21 CFR 211.110(a) and 21 CFR 211.113(b).
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Karen M. Cruz Arenas is dated Jun 5, 2024.